This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Aug 26;64(8):847-8.

doi: 10.1016/j.jacc.2014.04.074.

Knowing plasma concentrations improves management of the effects of dabigatran

Claudia Stöllberger, Josef Finsterer

PMID: 25145533
DOI: 10.1016/j.jacc.2014.04.074

Free article

Comment

Knowing plasma concentrations improves management of the effects of dabigatran

Claudia Stöllberger et al. J Am Coll Cardiol. 2014.

Free article

. 2014 Aug 26;64(8):847-8.

doi: 10.1016/j.jacc.2014.04.074.

Authors

Claudia Stöllberger, Josef Finsterer

PMID: 25145533
DOI: 10.1016/j.jacc.2014.04.074

No abstract available

PubMed Disclaimer

Comment on

The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).
Reilly PA, Lehr T, Haertter S, Connolly SJ, Yusuf S, Eikelboom JW, Ezekowitz MD, Nehmiz G, Wang S, Wallentin L; RE-LY Investigators. Reilly PA, et al. J Am Coll Cardiol. 2014 Feb 4;63(4):321-8. doi: 10.1016/j.jacc.2013.07.104. Epub 2013 Sep 27. J Am Coll Cardiol. 2014. PMID: 24076487 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information